美国 · 股市与财经 · MarketWatch

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

来源：MarketWatch · 美国 11 小时前

Zealand Pharma shares fell after German partner Boehringer Ingelheim reported results from a late-stage clinical trial of an obesity drug candidate licensed from the Danish…

在 MarketWatch 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketwatch.com)

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

推荐阅读

10-year Treasury yield hits highest level since 2002 as global bond rout gathers pace

Christian Ulbrich says working from the office is ‘core’. Just make sure it is a beautiful place to be as well

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

Indian Refiners Seek Tankers for Hormuz Oil

Morning Minute: Crypto Gives Up on Congress and Goes After Senators

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

分享

推荐阅读

10-year Treasury yield hits highest level since 2002 as global bond rout gathers pace

Christian Ulbrich says working from the office is ‘core’. Just make sure it is a beautiful place to be as well

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

Indian Refiners Seek Tankers for Hormuz Oil

Morning Minute: Crypto Gives Up on Congress and Goes After Senators